Viridian Therapeutics appoints Casciano as Chief Commercial officer

Viridian Therapeutics announced the appointment of Tony Casciano to the role of Chief Commercial Officer, CCO. The Company also announced that Chief Operating Officer, COO, Carrie Melvin is no longer with the organization. Casciano, who most recently served as Chief Executive Officer, CEO, and member of the board of directors of Teal Bio, brings to Viridian more than two decades of sales, marketing, and commercial leadership experience in the biopharma industry. Prior to leading Teal Bio, Casciano spent four years at AMAG Pharmaceuticals, serving initially as Senior Vice President, Head of U.S. Sales and Marketing before ascending to Executive Vice President, COO/CCO.